Honokiol potentiates pentobarbital-induced sleeping behaviors through GABAA receptor Cl- channel activation

Biomolecules and Therapeutics

Volumn 16, Issue 4, 2008, Pages 328-335

  Ma, Yuan ^a   Ma, Hong ^a   Jo, Young Jun ^a   Kim, Dong Seon ^b   Woo, Sung Sick ^b   Li, Rihua ^c   Hong, Jin Tae ^a   Moon, Dong Cheul ^a   Oh, Ki Wan ^a   Eun, Jae Soon ^c  

^a Chungbuk National University   (South Korea)

^b Unigen Inc   (South Korea)

^c Woosuk University   (South Korea)

Author keywords

Chloride influx; GABAA receptor; Honokiol; Pentobarbital; Sleep

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA; 4 AMINOBUTYRIC ACID A RECEPTOR BETA; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA; CHLORIDE CHANNEL; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; HONOKIOL; PENTOBARBITAL; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CEREBELLUM; CHLORIDE TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; FLUORESCENCE ANALYSIS; GRANULE CELL; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RAT; RIGHTING REFLEX; SLEEP; SLEEP TIME; WESTERN BLOTTING;

MUS;

EID: 69549107605     PISSN: 19769148     EISSN: None     Source Type: Journal    
DOI: 10.4062/biomolther.2008.16.4.328     Document Type: Article

References (39)

1. A receptor subtypes in vitro. Pharmacology 63, 34-41.
2. Battle, T. E., Arbiser, J. and Frank, D. A. (2005). The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood 106, 690-697. (Pubitemid 40981267)
3. A receptors reduces actions of alcohol and other drugs. J. Pharmacol. Exp. Ther. 304, 30-36.
4. Chebib, M. and Johnston, G. A. (2000). GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology. J. Med. Chem. 43, 1427-11247 (Pubitemid 30238425)
5. Chiang, C. K., Sheu, M. L., Hung, K. Y., Wu, K. D. and Liu, S. H. (2006). Honokiol, a small molecular weight natural product, alleviates experimental mesangial proliferative glomerulonephritis. Kidney Int. 70, 682-689.
6. Clark, A. M., El-Feraly, F. S. and Li, W. S. (1981). Antimicrobial activity of phenolic constituents of Magnolia grandiflora L. J. Pharm. Sci. 70, 951-952.
7. Cz3onkowska, A. I., Krzaoecik, P., Sienkiewicz-Jarosz, H., Siemiatkowski, M., Szyndler, J., Bidziñski, A. and P3aŸnik, A. (2000). The effects of neurosteroids on picrotoxin-, bicuculline- and NMDA-induced seizures, and a hypnotic effect of ethanol. Pharmacol. Biochem. Behav. 67, 345-353.
8. Darias, V., Abdala, S., Martin, H. D., Tello, M. L. and Vega, S. (1998). CNS effects of a series of 1,2,4-triazolyl heterocarboxylic derivatives. Pharmazie 53, 477-481. (Pubitemid 28338286)
9. Fukuyama, Y., Nakade, K., Minoshima, Y., Yokoyama, R., Zhai, H. and Mitsumoto, Y. (2002). Neurotrophic activity of honokiol on the cultures of fetal rat cortical neurons. Bioorg. Med. Chem. Lett. 12, 1163-1166. (Pubitemid 34270554)
10. Gottesmann, C. (2002). GABA mechanisms and sleep. Neuroscience 111, 231-239.
11. Han, H. S., Ma, Y., Eun, J. S., Hong, J. T. and Oh, K. W. (2007). Anxiolytic-like effects of methanol extract of Zizyphi Spinosi Semen in mice. J. Appl. Pharmacol. 15, 175-181.
12. Houston, C. M. and Smart, T. G. (2006). CaMK-II modulation of GABA(A) receptors expressed in HEK293, NG108-15 and rat cerebellar granule neurons. Eur. J. Neurosci. 24, 2504-2514.
13. Korpi, E. R., Gründer, G. and Lüddens, H. (2002). Drug interactions at GABA(A) receptors. Prog. Neurobiol. 67, 113-159.
14. Kuribara, H., Kishi, E., Hattori, N,, Okada, M. and Maruyama, Y. (2000). The anxiolytic effect of two oriental herbal drugs in Japan attributed to honokiol from magnolia bark. J. Pharm. Pharmacol. 2, 1425-1429.
15. Kuribara, H., Stavinoha, W. B. and Maruyama, Y. (1998). Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice. J. Pharm. Pharmacol. 50, 819-826. (Pubitemid 28379279)
16. Lee, J., Jung, E., Park, J., Jung, K., Lee, S., Hong, S., Park, J., Park, E., Kim, J., Park, S. and Park, D. (2005). Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling. Planta Med. 71, 338-343. (Pubitemid 40676458)
17. Liao, J. F., Huang, S. Y., Jan, Y. M., Yu, L. L. and Chen, C. F. (1998). Central inhibitory effects of water extract of Acori graminei rhizoma in mice. J. Ethnopharmacol. 61, 185-193.
18. Lin, Y. R., Chen, H. H., Ko, C. H. and Chan, M. H. (2005). Differential inhibitory effects of honokiol and magnolol on excitatory amino acid-evoked cation signals and NMDA-induced seizures. Neuropharmacol. 49, 542-550.
19. Liou, K. T., Shen, Y. C., Chen, C, F., Tsao, C. M. and Tsai, S. K. (2003a). The anti-inflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production. Eur. J. Pharmacol. 15, 19-27. (Pubitemid 37088002)
20. Liou, K. T., Shen, Y. C., Chen, C. F., Tsao, C. M. and Tsai, S. K. (2003b). Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production. Brain Res. 992, 159-166.
21. Liou, K. T., Lin, S. M., Huang, S. S., Chih, C. L. and Tsai, S. K. (2003c). Honokiol ameliorates cerebral infarction from ischemia-reperfusion injury in rats. Planta Med. 69, 130-134.
22. Li, Z., Liu, Y., Zhao, X., Pan, X., Yin, R., Huang, C., Chen, L. and Wei, Y. (2008). Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells. Eur. J. Obstet. Gynecol. Reprod. Biol. 140, 95-102.
23. Martínez, A. L., Domínguez, F., Orozco, S., Chávez, M., Salgado, H., González, M. and González-Trujano, M. E. (2006). Neuropharmacological effects of an ethanol extract of the Magnolia dealbata Zucc. leaves in mice. J. Ethnopharmacol. 106, 250-255.
24. Maruyama, Y., Kuribara, H., Kishi, E., Weintraub, S. T. and Ito, Y. (2001). Confirmation of the anxiolytic-like effect of dihydrohonokiol following behavioural and biochemical assessments. J. Pharm. Pharmacol. 53, 721-725. (Pubitemid 32457822)
25. Ma, Y., Han, H., Eun, J. S., Kim, H. C., Hong, J. T. and Oh, K. W. (2007). Sanjoinine A isolated from Zizyphi Spinosi Semen augments pentobarbital-induced sleeping behaviors through the modification of GABA-ergic systems. Biol. Pharm. Bull. 30, 1748-1753. (Pubitemid 47403257)
26. McKernan, R. M. and Whiting, P. J. (1996). Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci. 19, 139-143. (Pubitemid 26086496)
27. Olsen, R. W. (1981). GABA-benzodiazepine-barbiturate receptor interactions. J. Neurochem. 37, 1-13.
28. Pirker, S., Schwarzer, C., Wieselthaler, A., Sieghart, W. and Sperk, G. (2000). GABAA receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101, 815-850. (Pubitemid 30952906)
29. Rudolph, U. and Möhler, H. (2006). GABA-based therapeutic approaches: GABAA receptor subtype functions. Curr. Opin. Pharmacol. 6, 18-23. (Pubitemid 43103815)
30. Sheu, M. L., Chiang, C. K., Tsai, K. S., Ho, F. M., Weng, T. I., Wu, H. Y. and Liu, S. H. (2008). Inhibition of NADPH oxidase-related oxidative stress-triggered signaling by honokiol suppresses high glucose-induced human endothelial cell apoptosis. Free Radic. Biol. Med. 44, 2043-2050
31. Sheu, M. L., Liu, S. H. and Lan, K. H. (2007). Honokiol induces calpain-mediated glucose-regulated protein-94 cleavage and apoptosis in human gastric cancer cells and reduces tumor growth. PLoS. ONE. 2, 1096.
32. Sieghart, W. and Sperk, G. (2002). Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr. Top. Med. Chem. 2, 795-816.
33. Squires, R. F., Ai, J., Witt, M. R., Kahnberg, P., Saederup, E,. Sterner, O. and Nielsen, M. (1999). Honokiol and magnolol increase the number of [3H] muscimol binding sites three-fold in rat forebrain membranes in vitro using a filtration assay, by allosterically increasing the affinities of low-affinity sites. Neurochem. Res. 24, 1593-1602.
34. Ticku, M.K. and Maksay, G. (1983). Convulsant/depressant site of action at the allosteric benzodiazepine-GABA receptor-ionophore complex. Life Sci. 33, 2363-2375.
35. Wang, F., Li, J., Wu, C., Yang, J., Xu, F. and Zhao, Q. (2003). The GABA(A) receptor mediates the hypnotic activity of melatonin in rats. Pharmacol. Biochem. Behav. 74, 573-578. (Pubitemid 36126534)
36. West, M. R. and Molloy, C. R. (1996). A microplate assay measuring chloride ion channel activity. Anal. Biochem. 241, 51-58.
37. Wolfman, C., Viola, H., Marder, M., Wasowski, C., Ardenghi, P. and Izquierdo, I. (1996). Anxioselective properties of 6,3′-dinitroflavone, a high-affinity benzodiazepine receptor ligand. Eur. J. Pharmacol. 318, 23-30. (Pubitemid 27033199)
38. Xie, X., Crowder, T. L., Yamanaka, A., Morairty, S. R., Lewinter, R. D., Sakurai, T. and Kilduff, T. S. (2006). GABA(B) receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus. J. Physiol. 574, 399-414.
39. Yamada, K., Watanabe, Y., Aoyagi, Y. and Ohta, A. (2001). Effect of alkylpyrazine derivatives on the duration of pentobarbital- induced sleep, picrotoxicin-induced convulsion and gamma-aminobutyric acid (GABA) levels in the mouse brain. Biol. Pharm. Bull. 24, 1068-1071. (Pubitemid 32894131)